SACRAMENTO – A California woman alleges a medication used to treat heartburn and gastroesophageal reflux disease caused kidney damage.
and Gary Costamagna filed a complaint on Feb. 23 in the U.S. District
Court for the Eastern District of California against
The Procter & Gamble Co., Astrazeneca Pharmaceuticals LP and Does 1
to 50 alleging strict products liability, negligent misrepresentation
and loss of consortium.
According to the complaint, the
plaintiffs allege that in 2016, Penelope Costamagna suffered physical
injuries, including damages to her kidney, due to taking Prilosec. She
alleges she required a kidney transplant because of proton pump
inhibitor use. The plaintiffs holds The Procter & Gamble Co.,
Astrazeneca Pharmaceuticals LP and Does 1 to 50 responsible because the
defendants allegedly had a duty to include appropriate warnings against the continued use of the drug and failed to appropriately warn Penelope Costamagna's health care providers about the side effects and risks.
plaintiffs request a trial by jury and seek non-economic damages,
economic damages, all legal fees, interest, judgment of no more than
$5 million and any other relief as the court deems just. They are
represented by Clayeo C. Arnold and Joshua H. Watson of Clayeo C. Arnold
U.S. District Court for the Eastern District of California Case number 2:17-cv-00409-MCE-EFB